Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Pain 6Neoplasm Metastasis 6Bone Neoplasms 5Breast Neoplasms 3Prostatic Neoplasms 1Osteoporosis 1Hematologic Neoplasms 1Esophageal Neoplasms 1Carcinoma, Squamous Cell 1Bone Diseases, Metabolic 1Adenocarcinoma 1

Interventions

Zoledronic Acid 14Vitamin D 8Risedronic Acid 8Letrozole 7Calcium 7Calcium Carbonate 5Absorptiometry, Photon 5Cholecalciferol 4Denosumab 3Alendronate 3bicalutamide 2Resistance Training 2Nutrition Assessment 2Kyphoplasty 2Hormone Replacement Therapy 2Calcium Gluconate 2Calcium Citrate 2Aromatase Inhibitors 2Anastrozole 2xian ling gu bao 1parathyroid hormone-related peptide (1-36) 1X-Rays 1Toremifene 1Technetium 1Raloxifene Hydrochloride 1Radiotherapy 1Progestins 1Lysine Acetyltransferase 5 1Linseed Oil 1Ibandronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Osteoporosis × Ibandronic Acid × Clear all
NCT00824993 2018-09-13

Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients

M.D. Anderson Cancer Center

Phase 3 Completed
78 enrolled 7 charts
Other hematologic neoplasm

Bone Diseases, Metabolic, Osteoporosis, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡